Formula Systems (1985) Ltd.
NASDAQ:FORTYInformation Technology Services
-$6.41 today
- Market cap
- $1.82B
- Beta
- 0.16
- P/E (TTM)
- 2.7
- EPS (TTM)
- $41.41
- Dividend yield
- 12.80%
Volume 0.00M
Average 0.00M
Big Five Numbers
Formula Systems (1985) Ltd. growth analysis
Start with the long-run numbers that show whether FORTY compounds: return on capital and growth in sales, earnings, equity, and free cash flow.
Big Five Numbers
CAGR by period · ROIC shows average
| Metric | 10yr | 5yr | 3yr | 1yr |
|---|---|---|---|---|
EPS | N/A | N/A | -29.8% | -64.6% |
Revenue | N/A | N/A | +1.0% | -4.0% |
Equity | N/A | N/A | +15.1% | +29.4% |
Cash | N/A | N/A | +33.0% | +152.1% |
ROIC | N/A | 8.4% | 8.0% | 5.4% |
Analysis
Latest growth is strongest in Cash at +152.1% and weakest in EPS at -64.6%. Three-year average ROIC is 8.0%, which helps show whether that growth is being earned efficiently.
Growth analysis
Is growth accelerating or fading?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Revenue segments
Where does the growth come from?
Break revenue down by product and geography to see which parts of the business drive the trend.
Revenue by segment
Where FORTY earns its revenue, as reported in company filings
- Adjustments Member
- Software services
- MatrixMember
- Proprietary software products and related services
- SapiensMember
- MagicSoftwareMember
- Other
| Segment · FY2025 | Revenue | Share | YoY |
|---|---|---|---|
| Adjustments Member | $2.63B | 100.2% | — |
| Other | -$4.04M | -0.2% | -102.4% |
Figures in USD. Segments account for 99.1% of reported FY2025 revenue; $24.88M is not attributed to a segment. Smaller segments are grouped as "Other".
Free cash flow
Does growth turn into cash?
Check whether reported growth converts into free cash flow after capital spending.
Free Cash Flow
Net Income to FCF bridge
FY2025
Analysis
FY2025 free cash flow is $374.8M. FCF conversion is 1018.4% of net income. Operating cash flow was $391.1M, with capex of -$16.3M. The largest bridge item is D&A at $153.7M.
Price targets
What do analysts expect from the price?
Compare the current price with the low, average, and high analyst targets.
Wall Street price targets
1-year price history with analyst consensus target
Unlock analyst target range
Sign in free to see low, average, high targets and implied upside for FORTY.
Analyst ratings
How do analysts rate the stock?
Review the buy, hold, and sell split and recent upgrades and downgrades.
Analyst ratings
Buy, hold, and sell recommendations and recent rating changes
No analyst ratings available.
Competitor growth
How does Formula Systems (1985) Ltd. grow against peers?
Compare historical and forecast growth with similar companies.
Competitor Growth
Peer CAGR comparison & forward estimates
| Company | Market Cap | 10yr | 5yr | 3yr | Fwd |
|---|---|---|---|---|---|
Infosys Limited INFY | $49.90B | +7.8% | +8.3% | +3.4% | +4.0% (4yr)20 analysts |
Cognizant Technology Solutions Corporation CTSH | $28.17B | +5.4% | +4.9% | +2.8% | +4.0% (4yr)11 analysts |
EPAM Systems, Inc. EPAM | $8.32B | +19.6% | +15.5% | +4.2% | +4.0% (3yr)17 analysts |
ExlService Holdings, Inc. EXLS | $6.52B | +12.8% | +16.8% | +13.9% | +13.5% (3yr)7 analysts |
CCC Intelligent Solutions Holdings Inc. CCC | $4.54B | — | +10.8% | +10.5% | +8.8% (3yr)3 analysts |
DXC Technology Company DXC | $2.29B | +5.9% | -4.9% | -4.3% | -2.2% (3yr)4 analysts |
Concentrix Corporation CNXC | $2.00B | — | +15.8% | +15.8% | +0.0% (4yr)1 analysts |
Globant S.A. GLOB | $1.96B | +25.5% | +24.7% | +11.3% | +6.6% (4yr)11 analysts |
Innodata Inc. INOD | $1.22B | +15.7% | +34.0% | +47.1% | +3.1% (6yr)1 analysts |
The Hackett Group, Inc. HCKT | $330.39M | +1.6% | +5.0% | +1.3% | -3.6% (2yr)2 analysts |
Questions
Growth questions
Common questions about FORTY's growth, answered from reported and forecast figures.
Is FORTY growing revenue?
Revenue declined 4.0% year over year, from $2.76B to $2.65B.
Is FORTY turning growth into profit?
The latest net margin is 1.1%, which shows how much revenue became net income.
Continue the stock analysis
Jump to another research area for this company.